Cancer

February 1, 2007

An enduring legacy

By Stephen Doster
February 1, 2007

Edge of the world

By Bill Snyder
February 1, 2007

The science of large numbers

Cohort studies shed light on cancer

By Stephen Doster
February 1, 2007

Lwala diaries – a postscript

By Bill Snyder
February 1, 2007

High-tech surveillance

The power of proteomics

By Bill Snyder
February 1, 2007

What’s Caterpillar got to do with it?

The role of the private sector in cancer research

By Stephen Doster
February 1, 2007

Hitting the bull’s-eye

Targeted cancer therapies begin making their mark
By Leigh MacMillan, Ph.D.
February 1, 2007

One arrow’s not enough

By Leigh MacMillan, Ph.D.
February 1, 2007

The next targeted therapies

By Leigh MacMillan, Ph.D.
February 1, 2007

A quiver of cancer fighters

By Leigh MacMillan, Ph.D.
February 1, 2007

Turning genes on to turn cancer off

By Leigh MacMillan, Ph.D.
February 1, 2007

How to crack the cancer code

By Bill Snyder
February 1, 2007

Bonanza or boondoggle?

By Bill Snyder